T. Dekoning

Preclinical antitumor activity of bizelesin in mice.

J. Plowman, W. Waud, C. Carter, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065.

G. L. Clarke, J. Mcgovren, T. Dekoning, 1984, The Journal of antibiotics.

Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.

L. Li, T. Dekoning, T. Wallace, 1987, International journal of immunopharmacology.

Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065

M. Warpehoski, R. Kelly, J. Mcgovren, 1991, Investigational New Drugs.

Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.

W. C. Krueger, W. Krueger, R. Kelly, 1992, Cancer research.

Structure and activity relationship of several novel CC-1065 analogs

M. Warpehoski, W. Krueger, R. Kelly, 1987, Investigational New Drugs.

Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.

L. Li, T. Dekoning, T. Wallace, 1987, Cancer research.

Biochemicaland PharmacologicalEffectsof the Fermentation-derived AntitumorAgent, (aS,5S)-a-Amino-3-chloro-4,5-di hydro-5- isoxazoleaceticAcid(AT-i25)1

G. Grindey, A. E. Berger, T. Dekoning, 1979 .

Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.

D. Wilson, L. Li, T. Dekoning, 1987, Laboratory animal science.

Isolation and identification of a major metabolite of PNU-107859, an MMP inhibitor from the biliary fluid of rats.

M. Kuo, S. Mizsak, T. Dekoning, 1999, Journal of Pharmacy and Science.